These companies have a coordination problem.
They're all burning billions to incrementally one-up each other with no hope of these investments ever paying off since models are interchangeable and have no moat. They're trying to get regulators to step in and force a pause.
The investments don't pay off if they don't have (enough) revenue, but have you seen any indication either lab is not growing revenue fast enough?